Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Gene ; 606: 35-38, 2017 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-28069549

RESUMO

PURPOSE: Tobacco/nicotine dependence has a significant heritable component. Genome-wide association studies have associated the single nucleotide polymorphisms (SNPs) rs578776, rs16969968, rs6474412, rs3733829 and rs4105144 with nicotine dependence in Western European populations. We examined whether these SNPs influence nicotine dependence and successful treatment of tobacco dependence in the Czech middle-European population. MATERIALS AND METHODS: Variants were analysed by PCR-RFLP or by TaqMan assay in 807 adult heavy tobacco-dependent smokers - patients of the Centre for Treatment of Tobacco Dependence (Prague) as well as 1,362 self-reported non-smokers. RESULTS AND DISCUSSION: Except for rs3733829, association with tobacco dependence was confirmed for all other genetic variants. In agreement with previous studies, the strongest determinant of tobacco dependence was rs16969968 with OR (95%CI) 1.32 (1.08-1.62) for A allele carriers vs. GG comparison (P=0.003). In contrast, none of the analysed variants reached significance with respect to a 1-year course of successful tobacco dependence treatment (all P over 0.18) in a subset of 525 patients. CONCLUSION: We confirmed the association between variants within genes that code nicotinic-acetylcholine receptors (-A3, -A5 and -B3), CYP2A6/B6 and tobacco dependence development in the Czech population. The success of the tobacco dependence treatment was not influenced by the analysed SNPs.


Assuntos
Predisposição Genética para Doença , Polimorfismo de Nucleotídeo Único , Tabagismo/genética , Tabagismo/terapia , Adulto , Citocromo P-450 CYP2A6 , Citocromo P-450 CYP2B6/genética , Tchecoslováquia , Feminino , Estudo de Associação Genômica Ampla , Humanos , Masculino , Proteínas do Tecido Nervoso , Receptores Nicotínicos/genética
2.
Physiol Res ; 65(4): 651-659, 2016 11 08.
Artigo em Inglês | MEDLINE | ID: mdl-26988157

RESUMO

The mechanisms behind the changes of body weight after smoking cessation are only partially understood. To this end, we explored the possible effects of smoking cessation on incretin hormones, leptin and selected anthropometric, biochemical and other hormonal parameters. Twenty-two non-obese male adult smokers attending an ambulatory smoking cessation program in Prague, Czech Republic, were examined at the baseline. Thirteen patients (mean age 37.92+/-2.66 years, mean body mass index 25.56+/-0.69 kg/m(2)) successfully quit smoking and were examined three months after smoking cessation; relapsed smokers were not followed up. The patients underwent 2-h liquid meal test with Fresubin and repeated blood sampling for measurements of blood glucose, gastric inhibitory polypeptide (GIP), glucagon-like peptide 1 (GLP-1), amylin, insulin, leptin, peptide-YY (PYY) and pancreatic polypeptide (PP). Three months after smoking cessation, body weight increased (4.35+/-3.32 kg, p<0.001). Leptin levels increased significantly in all repeated samples, while levels of GIP, GLP-1, amylin, insulin, PYY and PP remained unchanged. In conclusions, smoking cessation increased leptin levels probably owing to weight gain while it did not influence incretin levels.


Assuntos
Incretinas/sangue , Leptina/sangue , Abandono do Hábito de Fumar , Fumar/sangue , Adulto , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Estudos Prospectivos
3.
Physiol Res ; 63(Suppl 3): S361-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25428741

RESUMO

Smoking is the most important cardiovascular (CV) risk factor. Stopping smoking halves the CV risk. Every clinician should provide a brief intervention with smokers. Intensive treatment should be available to those who need it. There are 37 Centers for Tobacco Dependence in the Czech Republic, which offer treatment including a psychobehavioral intervention and pharmacotherapy (varenicline, nicotine, bupropion). Czech physicians, pharmacists and nurses are regularly educated about smoking cessation. We describe the results of intensive treatment offered by our centers. Treatment includes screening (1 h), an intervention (2 h), and follow-up visits during the next 12 months. Among 3532 patients, 34.3 % had CO-validated abstinence at 12-months (including 489 patients who attended the screening visit + only the 12-month follow up visit). Among patients who underwent the intervention, the abstinence rate was 38.2 %. The majority of patients who underwent the intervention (N=2470) used some form of pharmacotherapy. After one year, the abstinence rate was 43.4 %, compared to 15.9 % (N=573) without pharmacotherapy. Only 28 % of patients came on the recommendation of a physician. Despite the decrease in CV risk following smoking cessation and the effectiveness of treatment, centers are underutilized.


Assuntos
Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/prevenção & controle , Abandono do Hábito de Fumar/métodos , Tabagismo/epidemiologia , Tabagismo/terapia , Adulto , Estudos de Coortes , República Tcheca/epidemiologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Fumar/epidemiologia , Fumar/terapia , Resultado do Tratamento
4.
Vnitr Lek ; 48(7): 671-4, 2002 Jul.
Artigo em Tcheco | MEDLINE | ID: mdl-12197412

RESUMO

The authors present the case of a 18-year-old boy examined on account of accidentally detected splenomegaly and suspected venous convolute in the region of the porta hepatis. Coeliacography revealed cavernous reconstruction of the portal vein due to an old thrombosis and thrombosis of the lineal vein. At the time of assessment of this diagnosis the patient had no apparent risk factor for the development of venous thromboembolic disease. With regard to the serious character of the finding and the patients age later detailed haemocoagulation, biochemical and genetic examinations were made. The only risk factor for the development of thrombosis which was detected was medium severe hyperhomocysteinaemia (46.7 mumol/l) with C677T mutation in the gene for 5,10-methylene tetrahydrofolate reductase in the homozygous state. Although hyperhomocysteinaemia was identified already in the past as an important risk factor for the development of venous thromboembolic disease, in the available literature so far no case of portal vein thrombosis was described in a patient with hyperhomocysteinaemia as the only apparent risk factor.


Assuntos
Hiper-Homocisteinemia/diagnóstico , Veia Porta , Trombose Venosa/etiologia , Adolescente , Humanos , Hiper-Homocisteinemia/complicações , Masculino , Trombose Venosa/diagnóstico
5.
Vopr Onkol ; 45(1): 26-8, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10941361

RESUMO

The methodology and end results of interstitial radiotherapy and combined and complex limb-preserving treatment for carcinoma of the mucosa of the tongue and fundus of the oral cavity have been studied. 60Co ionizing radiation pin-sources with high-level activity at tips were employed.


Assuntos
Raios gama/uso terapêutico , Soalho Bucal , Mucosa Bucal , Neoplasias Bucais/radioterapia , Neoplasias da Língua/radioterapia , Adulto , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Radioterapia/métodos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...